Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

AMBI seeks partners to develop oral nisin for H. pylori eradication

Dec. 2, 1998

Multiple clinical studies support efficacy and safety of HSR-237 in patients with IBS

Nov. 30, 1998

Ferring patents dual T-cell proliferation and protein farnesyltransferase inhibitors

Nov. 27, 1998

Potent and highly selective CCK-A antagonist designed by Tobishi

Nov. 26, 1998

New compounds for immunoinflammatory and neoplastic diseases in the pipeline at Ferring

Nov. 26, 1998

Shearwater Polymers will pegylate interferon alfa-2a for Roche under new agreement

Nov. 26, 1998

Major clinical trials demonstrate efficacy of Rebetron in chronic HCV infection

Nov. 23, 1998

Anti-H. pylori cephems in development at Takeda

Nov. 19, 1998

Lamivudine highlighted at recent Study for Liver Diseases meeting

Nov. 18, 1998

Triangle Pharmaceuticals presents preliminary data on FTC in HBV patients

Nov. 18, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...